Risk Stratification Using Oxygenation in the First 24 Hours of Pediatric Acute Respiratory Distress Syndrome

Nadir Yehya1, Neal J Thomas2, Robinder G Khemani3,4

  • 1Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA.

Critical Care Medicine
|January 3, 2018
PubMed

Insights

Early oxygenation measurements in pediatric acute respiratory distress syndrome (ARDS) effectively predict outcomes. Measuring oxygenation 6-12 hours after ARDS onset provides valuable risk stratification for critically ill children.

Area of Science:

  • Pediatric Critical Care Medicine
  • Respiratory Physiology
  • Clinical Trial Design

Background:

  • Oxygenation indices are crucial for assessing severity and outcomes in acute respiratory distress syndrome (ARDS).
  • While 24-hour post-onset oxygenation is predictive, its delay poses challenges for early therapeutic interventions.
  • Earlier predictive markers are needed for timely management in pediatric ARDS.

Purpose of the Study:

  • To determine if oxygenation measurements earlier than 24 hours after onset can predict outcomes in pediatric acute respiratory distress syndrome.
  • To evaluate the predictive validity of PaO2/FIO2 and oxygenation index at various early timepoints.

Main Methods:

  • An observational cohort study was conducted in two academic pediatric intensive care units.
  • Invasively ventilated children with ARDS were included (n=459).
  • PaO2/FIO2 and oxygenation index were measured at ARDS onset and at 6, 12, 18, and 24 hours. Outcomes included mortality and ventilator-free days.

Main Results:

  • Neither PaO2/FIO2 nor oxygenation index at ARDS onset predicted outcomes.
  • Between 6 and 24 hours, both indices demonstrated good discrimination and calibration for mortality, ventilator-free days, and extubation probability.
  • Oxygenation at 12 hours showed confirmed utility in an independent cohort.

Conclusions:

  • Oxygenation measurements between 6 and 12 hours post-ARDS onset accurately stratify outcomes in children.
  • These findings support earlier risk stratification, impacting clinical trial design for early ARDS interventions.
  • This study highlights the importance of early physiological monitoring in pediatric ARDS management.
Abstract

Related Concept Videos

Holter Monitor: 24-Hour Monitoring01:23

Holter Monitor: 24-Hour Monitoring

Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...
2.9K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.1K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
521
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.1K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
960